QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,036 signal articles · 527 in last 24h · 103,484 total before filter · latest 32m ago
527last 24h
2508last 7d
482● bullish (7d)
256● bearish (7d)
197publishers
AllMacro242Earnings1479M&A140Regulatory16Product4Analyst29
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com2h agobullish
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

Investing.com3h agobullish
Shopify surges, AMD slides premarket as earnings disappoint

Investing.com - U.S. stock index futures were broadly higher on Wednesday as investors drew cautious optimism from signs that negotiations to reopen the Strait of Hormuz could be gaining traction, although disappointing reactions to earnings from Advanced Micro Devices and privately held SpaceX tempered enthusiasm for technology shares.

Regal Rexnord (RRX) Tops Q2 Earnings Estimates
Zacks3h agobullish
Regal Rexnord (RRX) Tops Q2 Earnings Estimates

Regal Rexnord (RRX) delivered earnings and revenue surprises of +15.00% and -1.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Clear Secure shares climb after earnings beat and stronger outlook
InvestorsHub3h agobullish
Clear Secure shares climb after earnings beat and stronger outlook

Clear Secure (NYSE:YOU) shares rose more than 6% in pre-market trading on Wednesday after the identity technology company reported second-quarter results that topped Wall Street expectations and issued stronger guidance for the months ahead. The company posted adjusted earnings of $0.

CVS Stock Rises Near Buy Point On Hearty Earnings Checkup
Investor's Business Daily3h agobullish
CVS Stock Rises Near Buy Point On Hearty Earnings Checkup

CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.

Investing.com3h agobullish
Shopify soars on strong revenue beat, robust guidance

Investing.com -- Shopify Inc. (NASDAQ: SHOP) reported second-quarter results that exceeded analyst expectations on both revenue and earnings, sending shares up 26% premarket as the company delivered accelerating growth across key metrics.

Lilly Stock Jumps on Earnings Beat as Mounjaro Revenue Nearly Doubles
Barrons.com4h agobullish
Lilly Stock Jumps on Earnings Beat as Mounjaro Revenue Nearly Doubles

Eli Lilly posted a blockbuster second quarter fueled by continued demand for its portfolio of GLP-1 medications. The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.